BlackRock’s NeuBase Therapeutics, Inc. Common Stock NBSE Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q1 | – | Sell |
-84
| Closed | -$62 | – | 5318 |
|
2023
Q4 | $62 | Sell |
84
-356
| -81% | -$263 | ﹤0.01% | 5264 |
|
2023
Q3 | $383 | Sell |
440
-24
| -5% | -$21 | ﹤0.01% | 5293 |
|
2023
Q2 | $868 | Sell |
464
-3,355
| -88% | -$6.28K | ﹤0.01% | 5325 |
|
2023
Q1 | $14.1K | Buy |
3,819
+101
| +3% | +$374 | ﹤0.01% | 5205 |
|
2022
Q4 | $14.1K | Buy |
3,718
+62
| +2% | +$236 | ﹤0.01% | 5335 |
|
2022
Q3 | $29K | Sell |
3,656
-104
| -3% | -$825 | ﹤0.01% | 5367 |
|
2022
Q2 | $80K | Sell |
3,760
-11
| -0.3% | -$234 | ﹤0.01% | 5210 |
|
2022
Q1 | $141K | Sell |
3,771
-155
| -4% | -$5.8K | ﹤0.01% | 5113 |
|
2021
Q4 | $220K | Sell |
3,926
-160
| -4% | -$8.97K | ﹤0.01% | 5014 |
|
2021
Q3 | $295K | Sell |
4,086
-262
| -6% | -$18.9K | ﹤0.01% | 4823 |
|
2021
Q2 | $416K | Sell |
4,348
-42,122
| -91% | -$4.03M | ﹤0.01% | 4667 |
|
2021
Q1 | $6.87M | Buy |
46,470
+8
| +0% | +$1.18K | ﹤0.01% | 3731 |
|
2020
Q4 | $6.5M | Buy |
46,462
+1,147
| +3% | +$160K | ﹤0.01% | 3513 |
|
2020
Q3 | $6.88M | Sell |
45,315
-1,318
| -3% | -$200K | ﹤0.01% | 3344 |
|
2020
Q2 | $8.19M | Buy |
46,633
+44,030
| +1,692% | +$7.73M | ﹤0.01% | 3232 |
|
2020
Q1 | $371K | Hold |
2,603
| – | – | ﹤0.01% | 4043 |
|
2019
Q4 | $375K | Buy |
2,603
+1,565
| +151% | +$225K | ﹤0.01% | 4149 |
|
2019
Q3 | $104K | Hold |
1,038
| – | – | ﹤0.01% | 4384 |
|
2019
Q2 | $71K | Hold |
1,038
| – | – | ﹤0.01% | 4483 |
|
2019
Q1 | $47K | Buy |
1,038
+1
| +0.1% | +$45 | ﹤0.01% | 4436 |
|
2018
Q4 | $35K | Buy |
1,037
+4
| +0.4% | +$135 | ﹤0.01% | 4475 |
|
2018
Q3 | $77K | Buy |
1,033
+1
| +0.1% | +$75 | ﹤0.01% | 4427 |
|
2018
Q2 | $81K | Buy |
1,032
+3
| +0.3% | +$235 | ﹤0.01% | 4438 |
|
2018
Q1 | $91K | Sell |
1,029
-18
| -2% | -$1.59K | ﹤0.01% | 4306 |
|
2017
Q4 | $779K | Buy |
1,047
+2
| +0.2% | +$1.49K | ﹤0.01% | 3913 |
|
2017
Q3 | $301K | Buy |
1,045
+3
| +0.3% | +$864 | ﹤0.01% | 4081 |
|
2017
Q2 | $267K | Sell |
1,042
-264
| -20% | -$67.6K | ﹤0.01% | 4124 |
|
2017
Q1 | $435K | Buy |
+1,306
| New | +$435K | ﹤0.01% | 3955 |
|